Search
for
Sort by
Research 31–60 of 1000+
- The Role of Labrasol® in the Enhancement of the Cutaneous Bioavailability of Minoxidil in Phospholipid Vesicles
- Incorporation of Isotopically Labeled Cocaine and Metabolites into Human Hair: 1. Dose-Response Relationships
- Mutant laboratory mice with abnormalities in hair follicle morphogenesis, cycling, and/or structure: annotated tables
- Mutant laboratory mice with abnormalities in hair follicle morphogenesis, cycling, and/or structure: An update
- Nonviral in Situ Green Fluorescent Protein Labeling and Culture of Primary, Adult Human Hair Follicle Epithelial Progenitor Cells
- Off-Label Use of Topical Minoxidil in Alopecia: A Review
- Off-Label Uses of Topical Vitamin D in Dermatology: A Systematic Review
- Gradient-dependent release of the model drug TRITC-dextran from FITC-labeled BSA hydrogel nanocarriers in the hair follicles of porcine ear skin
- Flexible label-free SERS substrate with alginate-chitosan@silver nanocube for in situ nondestructive detection of thiram on apples
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Solid state NMR of isotope labelled murine fur: a powerful tool to study atomic level keratin structure and treatment effects
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- Optimal laboratory testing protocol for patients with acne taking oral isotretinoin
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Controversies in off‐label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies
- Off-label uses of retinoids in dermatology
- Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art
- Spatiotemporal Labeling of Melanocytes in Mice
- Off-label prescriptions: patient safety first
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Entrepreneurship in Off-Label Drug Prescription: Just What the Doctor Ordered!
- Off-label dermatologic uses of IL-23 inhibitors
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Open-label placebos reduce hair cortisol concentrations and psychological distress - a randomized controlled trial
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- Broad laboratory testing does not show utility for telogen effluvium: a retrospective analysis of 22-million laboratory results using TriNetX
- DAB-labelling for collagen type III and PDGFR as control on equine skin sections.
- 28 OSHA, Laboratory Screening, and Office-Based Surgery
- The laboratory in the multidisciplinary diagnosis of differences or disorders of sex development (DSD)
- Off-label Prescription and Challenges in Clinical Practice: An Abridged Review